Telix Pharmaceuticals Limited (TLX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Telix Pharmaceuticals Lim...

    NASDAQ: TLX · Real-Time Price · USD
    10.28
    0.06 (0.59%)
    At close: Oct 03, 2025, 3:59 PM
    10.28
    0.00%
    After-hours: Oct 03, 2025, 06:06 PM EDT

    Telix Pharmaceuticals Cash Flow Statement

    Financials in AUD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Net Income
    		 -3.48M -11.68M 11.68M 19.53M -14.32M -33.19M -70.89M -48M -32.51M
    Depreciation & Amortization
    		 14.56M -2M 2M 3.64M 3.29M 2.66M 2.74M 2.63M 2.81M
    Stock-Based Compensation
    		 17.6M n/a n/a 7.47M 1.31M 5.84M 2.27M -767K 2.09M
    Other Working Capital
    		 n/a -64.27M n/a -20.52M n/a -3.69M n/a 2.6M n/a
    Other Non-Cash Items
    		 -1.72M 81.89M 21.3M -5.27M 30.86M 32.09M 13.41M 19.94M 6.68M
    Deferred Income Tax
    		 n/a n/a n/a 42.78M n/a 16.89M n/a 5.52M n/a
    Change in Working Capital
    		 n/a -64.27M n/a -57.53M n/a -28.64M n/a -7.42M n/a
    Operating Cash Flow
    		 26.97M 3.95M 34.98M 10.63M 13.26M -3.75M -60.22M -30.68M -28.65M
    Capital Expenditures
    		 -10.13M -20.34M -13.7M -7.79M -3.01M -4.66M -9.2M -1.01M -332K
    Cash Acquisitions
    		 -348.97M -11.51M -23.19M -123K 123K -973K n/a n/a n/a
    Purchase of Investments
    		 n/a -51.99M 4K -13.15M n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 -34.2M -25.21M -8.74M -1.54M n/a -25K -2.14M -941K -446K
    Investing Cash Flow
    		 -393.3M -89.33M -45.62M -22.6M -2.89M -5.66M -11.34M -1.95M -778K
    Debt Repayment
    		 -5.47M 652.81M 1.5M 639.28K n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 1.03M -18.5M 2.12M 4.48M 4.7M 3.79M 171.17M 2.51M 339K
    Financial Cash Flow
    		 -4.44M 635.3M 3.62M 5.49M 4.7M 3.79M 171.17M 2.51M 339K
    Net Cash Flow
    		 314.75M 591.51M -3.87M -8.49M 15.4M -6.28M 100.57M -27.58M -28.33M
    Free Cash Flow
    		 16.84M -10.92M 19.91M 2.84M 10.25M -8.41M -69.42M -31.69M -28.98M

    Add to Watchlist